Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19
Coronavirus patients taking hydroxychloroquine, a treatment touted by President Trump, were no less likely to need mechanical ventilation and had higher deaths rates compared to those who did not take the drug, according to a study of hundreds of patients at US Veterans Health Administration medical centers.
The study, which reviewed veterans' medical charts, was posted Tuesday on medrxiv.org, a pre-print server, meaning it was not peer reviewed or published in a medical journal.
The research was funded by the National Institutes of Health and the University of Virginia.
In the study of 368 patients, 97 patients who took hydroxychloroquine had a 27.8% death rate. The 158 patients who did not take the drug had an 11.4% death rate.
French study finds hydroxychloroquine doesn't help patients with coronavirus
A drug that's been touted by President Donald Trump as a "game changer" didn't help hospitalized patients with coronavirus and was associated with heart complications, according to a new study.
"This provides evidence that hydroxychloroquine does not apparently treat patients with Covid 19," said Dr. Paul Offit, an infectious disease specialist at Children's Hospital of Philadelphia.
"Even worse, there were side effects caused by the drug -- heart toxicities that required it be discontinued."
No comments:
Post a Comment